Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
RTS,S is the most advanced malaria vaccine candidate, currently under phase-III clinical trials in Africa. This Plasmodium falciparum vaccine contains part of the central repeat region and the complete C-terminal T cell epitope region (Th2R and Th3R) of the circumsporozoite protein (CSP). Since natu...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2012
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/e93356ca7e9d4fa895a299418020c96b |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:e93356ca7e9d4fa895a299418020c96b |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:e93356ca7e9d4fa895a299418020c96b2021-11-18T07:08:21ZGenetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.1932-620310.1371/journal.pone.0043430https://doaj.org/article/e93356ca7e9d4fa895a299418020c96b2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22912873/?tool=EBIhttps://doaj.org/toc/1932-6203RTS,S is the most advanced malaria vaccine candidate, currently under phase-III clinical trials in Africa. This Plasmodium falciparum vaccine contains part of the central repeat region and the complete C-terminal T cell epitope region (Th2R and Th3R) of the circumsporozoite protein (CSP). Since naturally occurring polymorphisms at the vaccine candidate loci are critical determinants of the protective efficacy of the vaccines, it is imperative to investigate these polymorphisms in field isolates. In this study we have investigated the genetic diversity at the central repeat, C-terminal T cell epitope (Th2R and Th3R) and N-terminal T cell epitope regions of the CSP, in P. falciparum isolates from Madhya Pradesh state of India. These isolates were collected through a 5-year prospective study aimed to develop a well-characterized field-site for the future evaluation of malaria vaccine in India. Our results revealed that the central repeat (63 haplotypes, n = 161) and C-terminal Th2R/Th3R epitope (24 haplotypes, n = 179) regions were highly polymorphic, whereas N-terminal non-repeat region was less polymorphic (5 haplotypes, n = 161) in this population. We did not find any evidence of the role of positive natural selection in maintaining the genetic diversity at the Th2R/Th3R regions of CSP. Comparative analysis of the Th2R/Th3R sequences from this study to the global isolates (n = 1160) retrieved from the GenBank database revealed two important points. First, the majority of the sequences (~61%, n = 179) from this study were identical to the Dd2/Indochina type, which is also the predominant Th2R/Th3R haplotype in Asia (~59%, n = 974). Second, the Th2R/Th3R sequences in Asia, South America and Africa are geographically distinct with little allele sharing between continents. In conclusion, this study provides an insight on the existing polymorphisms in the CSP in a parasite population from India that could potentially influence the efficacy of RTS,S vaccine in this region.Mohammad ZeeshanMohammad Tauqeer AlamSumiti VinayakHema BoraRupesh Kumar TyagiMohd Shoeb AlamVandana ChoudharyPooja MittraVanshika LumbPraveen Kumar BhartiVenkatachalam UdhayakumarNeeru SinghVidhan JainPushpendra Pal SinghYagya Dutta SharmaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 8, p e43430 (2012) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Mohammad Zeeshan Mohammad Tauqeer Alam Sumiti Vinayak Hema Bora Rupesh Kumar Tyagi Mohd Shoeb Alam Vandana Choudhary Pooja Mittra Vanshika Lumb Praveen Kumar Bharti Venkatachalam Udhayakumar Neeru Singh Vidhan Jain Pushpendra Pal Singh Yagya Dutta Sharma Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine. |
| description |
RTS,S is the most advanced malaria vaccine candidate, currently under phase-III clinical trials in Africa. This Plasmodium falciparum vaccine contains part of the central repeat region and the complete C-terminal T cell epitope region (Th2R and Th3R) of the circumsporozoite protein (CSP). Since naturally occurring polymorphisms at the vaccine candidate loci are critical determinants of the protective efficacy of the vaccines, it is imperative to investigate these polymorphisms in field isolates. In this study we have investigated the genetic diversity at the central repeat, C-terminal T cell epitope (Th2R and Th3R) and N-terminal T cell epitope regions of the CSP, in P. falciparum isolates from Madhya Pradesh state of India. These isolates were collected through a 5-year prospective study aimed to develop a well-characterized field-site for the future evaluation of malaria vaccine in India. Our results revealed that the central repeat (63 haplotypes, n = 161) and C-terminal Th2R/Th3R epitope (24 haplotypes, n = 179) regions were highly polymorphic, whereas N-terminal non-repeat region was less polymorphic (5 haplotypes, n = 161) in this population. We did not find any evidence of the role of positive natural selection in maintaining the genetic diversity at the Th2R/Th3R regions of CSP. Comparative analysis of the Th2R/Th3R sequences from this study to the global isolates (n = 1160) retrieved from the GenBank database revealed two important points. First, the majority of the sequences (~61%, n = 179) from this study were identical to the Dd2/Indochina type, which is also the predominant Th2R/Th3R haplotype in Asia (~59%, n = 974). Second, the Th2R/Th3R sequences in Asia, South America and Africa are geographically distinct with little allele sharing between continents. In conclusion, this study provides an insight on the existing polymorphisms in the CSP in a parasite population from India that could potentially influence the efficacy of RTS,S vaccine in this region. |
| format |
article |
| author |
Mohammad Zeeshan Mohammad Tauqeer Alam Sumiti Vinayak Hema Bora Rupesh Kumar Tyagi Mohd Shoeb Alam Vandana Choudhary Pooja Mittra Vanshika Lumb Praveen Kumar Bharti Venkatachalam Udhayakumar Neeru Singh Vidhan Jain Pushpendra Pal Singh Yagya Dutta Sharma |
| author_facet |
Mohammad Zeeshan Mohammad Tauqeer Alam Sumiti Vinayak Hema Bora Rupesh Kumar Tyagi Mohd Shoeb Alam Vandana Choudhary Pooja Mittra Vanshika Lumb Praveen Kumar Bharti Venkatachalam Udhayakumar Neeru Singh Vidhan Jain Pushpendra Pal Singh Yagya Dutta Sharma |
| author_sort |
Mohammad Zeeshan |
| title |
Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine. |
| title_short |
Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine. |
| title_full |
Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine. |
| title_fullStr |
Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine. |
| title_full_unstemmed |
Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine. |
| title_sort |
genetic variation in the plasmodium falciparum circumsporozoite protein in india and its relevance to rts,s malaria vaccine. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2012 |
| url |
https://doaj.org/article/e93356ca7e9d4fa895a299418020c96b |
| work_keys_str_mv |
AT mohammadzeeshan geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine AT mohammadtauqeeralam geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine AT sumitivinayak geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine AT hemabora geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine AT rupeshkumartyagi geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine AT mohdshoebalam geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine AT vandanachoudhary geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine AT poojamittra geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine AT vanshikalumb geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine AT praveenkumarbharti geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine AT venkatachalamudhayakumar geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine AT neerusingh geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine AT vidhanjain geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine AT pushpendrapalsingh geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine AT yagyaduttasharma geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine |
| _version_ |
1718423888204922880 |